rxstat › Classes › Immunosuppressants
Immunosuppressants: shortage status in Canada
10 of the 20 immunosuppressants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Widespread shortageApremilast2 of 3 reported products affectedPartial shortageAdalimumab1 of 7 reported products affectedPartial shortageApremilast Apremilast Apremilast1 of 1 reported products affected · est. return Aug 28, 2026Partial shortageBasiliximab1 of 1 reported products affectedPartial shortageCyclosporine1 of 8 reported products affected · est. return Jul 30, 2027Partial shortageLenalidomide2 of 7 reported products affected · est. return Aug 28, 2026Partial shortageMycophenolate Mofetil4 of 16 reported products affected · est. return Jul 10, 2026Partial shortagePirfenidone3 of 10 reported products affected · est. return Sep 19, 2026Partial shortageTacrolimus2 of 6 reported products affectedPartial shortageTocilizumab1 of 7 reported products affectedNo current shortageAbataceptNo current shortageAzathioprineDiscontinuedCanakinumab0 of 1 reported products affectedDiscontinuedDaclizumab Beta0 of 1 reported products affectedNo current shortageEtanerceptNo current shortageIxekizumabNo current shortageMycophenolic AcidNo current shortageSiltuximabNo current shortageSirolimusDiscontinuedWater Etanercept0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.